Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 276 No 7382 p21
7 January 2006


Society summary


Patient safety vital in transfer of home oxygen service, says Society

The need to maintain patient safety during the transfer of the home oxygen service in England and Wales from community pharmacies to regional oxygen supply companies has been emphasised by the Royal Pharmaceutical Society. Four regional contractors will supply both cylinders and concentrators as part of an integrated service from 1 February — four months after the originally intended date.

The Society says that the delay has caused confusion and there are worries that some patients may be left without oxygen when the new service begins. To address these concerns the Society calls on primary care trusts and pharmacists to work together to ensure that the new service is implemented as smoothly as possible and with minimal risk to patients.

The Society is also helping pharmacists to direct their patients towards sources of advice and information about the new arrangements. Four key points have been identified for pharmacists to bear in mind (see Panel).

Key points

· Patients unable to obtain oxygen before 1 February should contact their local primary care trust. Patients unable to obtain oxygen after 1 February should telephone their new supplier using a 24-hour emergency hotline number:

Air Products
0800 373580

Allied Respiratory
0500 823773

BOC Vitalair
0800 136603

Linde
0808 2020999

· A single supplier will meet all patients’ home oxygen needs, whether cylinder, concentrator or liquid oxygen

· Worried patients can be advised to call NHS Direct (tel 0845 4647), which will explain the changes and print copies of the NHS leaflet about home oxygen supply and send to callers if they do not have access to the internet

· A new section of the primary care contracting website provides details of the home oxygen service and includes a range of materials for pharmacists to download.

Council Member Sid Dajani, who chairs the Practice Committee, says: “Importantly, we would encourage pharmacists to ask patients to ensure they have oxygen supplies leading up to the transition period to minimise the need for the new supplier to make emergency supplies during the handover period.”

To help pharmacists, national pharmacy organisations have developed a template letter for community pharmacists to disseminate to their patients during this period of transition. It is available from the Pharmaceutical Services Negotiating Committee website

Back to Top


©The Pharmaceutical Journal